Publicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (198)

2024

  1. Gastric GDF15 levels are regulated by age, sex, and nutritional status in rodents and humans

    Journal of Endocrinological Investigation, Vol. 47, Núm. 5, pp. 1139-1154

  2. Semaglutide modulates prothrombotic and atherosclerotic mechanisms, associated with epicardial fat, neutrophils and endothelial cells network

    Cardiovascular Diabetology, Vol. 23, Núm. 1

2023

  1. Diminishing benefits of urban living for children and adolescents’ growth and development

    Nature, Vol. 615, Núm. 7954, pp. 874-883

  2. Editorial: Central and peripheral mechanism interfering in metabolic syndrome

    Frontiers in Endocrinology

  3. Expert Consensus on Morphofunctional Assessment in Disease-Related Malnutrition. Grade Review and Delphi Study

    Nutrients, Vol. 15, Núm. 3

  4. Extracellular Vesicles as Carriers of Adipokines and Their Role in Obesity

    Biomedicines, Vol. 11, Núm. 2

  5. Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c

    Nature Medicine, Vol. 29, Núm. 11, pp. 2885-2901

  6. NEmecum: digital tool for assisting in the prescription and dispensing of enteral nutrition formulas and infant preparations

    Nutricion Hospitalaria, Vol. 40, Núm. 5, pp. 924-933

  7. Protocol for a prospective cohort study on the feasibility of application of nutritional ultrasound in the diagnosis and follow-up of patients with nutritional risk at hospital discharge: study on body composition and function (DRECO)

    BMJ Open, Vol. 13, Núm. 12

2022

  1. Data mining analyses for precision medicine in acromegaly: a proof of concept

    Scientific Reports, Vol. 12, Núm. 1

  2. Executive summary of the consensus statement of: Clinical recommendations for sport practice in people with diabetes (RECORD Guide). Update 2021. Diabetes Mellitus Area of the Spanish Society of Endocrinology and Nutrition (SEEN)

    Endocrinologia, Diabetes y Nutricion, Vol. 69, Núm. 9, pp. 732-743

  3. Fibroblast growth factor 21 levels and liver inflammatory biomarkers in obese subjects after weight loss

    Archives of Medical Science, Vol. 18, Núm. 1, pp. 36-44

  4. How the COVID-19 pandemic has affected the training of Endocrinology and Nutrition Residents. Results of a survey by the Spanish Society of Endocrinology and Nutrition

    Endocrinologia, Diabetes y Nutricion, Vol. 69, Núm. 3, pp. 219-226

  5. Human obese white adipose tissue sheds depot-specific extracellular vesicles and reveals candidate biomarkers for monitoring obesity and its comorbidities

    Translational Research, Vol. 239, pp. 85-102

  6. Immunomodulatory effect of a very-low-calorie ketogenic diet compared with bariatric surgery and a low-calorie diet in patients with excessive body weight

    Clinical Nutrition, Vol. 41, Núm. 7, pp. 1566-1577

  7. Implications of Heterogeneity of Epithelial-Mesenchymal States in Acromegaly Therapeutic Pharmacologic Response

    Biomedicines, Vol. 10, Núm. 2

  8. Kappa-Opioid Receptor Blockade Ameliorates Obesity Caused by Estrogen Withdrawal via Promotion of Energy Expenditure through mTOR Pathway

    International Journal of Molecular Sciences, Vol. 23, Núm. 6

  9. Liver Brain Interactions: Focus on FGF21 a Systematic Review

    International Journal of Molecular Sciences, Vol. 23, Núm. 21

  10. Metabolic actions of the growth hormone-insulin growth factor-1 axis and its interaction with the central nervous system

    Reviews in Endocrine and Metabolic Disorders, Vol. 23, Núm. 5, pp. 919-930

  11. Pituitary tumor centers of excellence for Cushing’s disease

    Pituitary, Vol. 25, Núm. 5, pp. 772-775